PlumX Metrics
Embed PlumX Metrics

Osteonecrosis and Bisphosphonates in Oral and Maxillofacial Surgery

Oral and Maxillofacial Surgery Clinics of North America, ISSN: 1042-3699, Vol: 19, Issue: 2, Page: 199-206
2007
  • 17
    Citations
  • 0
    Usage
  • 87
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

Bisphosphonates are a class of compounds approved for the treatment of multiple myeloma, hypercalcemia of malignancy, osteolytic lesions of metastatic disease, Paget's disease, and most commonly, osteoporosis. Recently, these drugs have been associated with a new clinical entity, bisphosphonate related osteonecrosis (BRON) which is characterized by jaw necrosis that typically presents following dentoalveolar surgery. The pathogenesis for this complication appears to related to bisphosphonate mediated inhibition of osteoclast function and normal bone remodeling. This complication can have a significant impact on the quality of life for those patients with advanced stages of necrosis.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know